Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Respiratory & Pulmonary market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

243 Item(s)

Page 1 of 25

  1. Obstructive Sleep Apnea - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8716IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obstructive Sleep Apnea – Pipeline Review, H2 2016, provides an overview of the Obstructive Sleep Apnea (Respiratory) pipeline landscape.
    $2,000.00

  2. Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Oct-2016
    , Product code: GMDHC8608IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2016, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.
    $2,000.00

  3. Asthma - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Oct-2016
    , Product code: GMDHC8567IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.
    $2,500.00

  4. Bronchiectasis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Oct-2016
    , Product code: GMDHC8587IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis – Pipeline Review, H2 2016, provides an overview of the Bronchiectasis (Respiratory) pipeline landscape.
    $2,000.00

  5. Global Breath Analyzers Market 2016-2020

    By: Technavio
    , Published: Oct-2016
    , Product code: IRTNTR10474
    The report covers the present scenario and the growth prospects of the global breath analyzers market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of breath analyzers at their retail prices.
    $2,500.00

  6. Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Oct-2016
    , Product code: GMDHC8528IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline landscape.
    $2,000.00

  7. Global Cystic Fibrosis Therapeutics Market 2016-2020

    By: Technavio
    , Published: Oct-2016
    , Product code: IRTNTR10588
    The report covers the present scenario and the growth prospects of the global cosmetic surgery market for 2016-2020. To calculate the market size, the report considers the revenue generated from the execution of the different types of cosmetic surgeries.
    $2,500.00

  8. Emphysema - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Sep-2016
    , Product code: GMDHC8515IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Emphysema – Pipeline Review, H2 2016, provides an overview of the Emphysema (Respiratory) pipeline landscape.
    $2,000.00

  9. Cystic Fibrosis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Sep-2016
    , Product code: GMDHC8474IDB
    The report provides comprehensive information on the therapeutics under development for Cystic Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects.
    $2,000.00

  10. Pulmonary Fibrosis - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Sep-2016
    , Product code: GMDHC8475IDB
    The report provides comprehensive information on the therapeutics under development for Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Fibrosis and features dormant and discontinued projects.
    $2,000.00

243 Item(s)

Page 1 of 25